Table 2.
Total | TAU group | Intervention groupa | Treatment effectb | |||||
---|---|---|---|---|---|---|---|---|
Probability of higher disclosure distress | % | (SE) | % | (SE) | % | (SE) | OR | 95% CI |
Baseline | 50.00 | (0.52) | 50.00 | (0.53) | 50.00 | (0.53) | – | – |
4 weeks | 40.00 | (0.50) | 50.00 | (0.53) | 30.00(S) | (0.48) | 0.43 | 0.08–2.28 |
13 weeks | 25.00 | (0.44) | 40.00 | (0.52) | 10.00*(L) | (0.32) | 0.17** | 0.03–0.91 |
Probability of higher disclosure self-efficacy | % | (SE) | % | (SE) | % | (SE) | OR | 95% CI |
Baseline | 35.00 | (0.49) | 20.00 | (0.42) | 50.00 | (0.53) | – | – |
4 weeks | 55.00 | (0.51) | 20.00 | (0.42) | 90.00***(L) | (0.32) | 9.00*** | 2.06–39.29 |
13 weeks | 65.00 | (0.49) | 40.00 | (0.52) | 90.00***(L) | (0.32) | 3.38 | 0.45–25.36 |
Position on disclosure behaviours continuum | Mean | (SE) | Mean | (SE) | Mean | (SE) | Beta | 95% CI |
Baseline | 0.95 | (0.33) | 0.70 | (0.30) | 1.20 | (0.60) | – | – |
4 weeks | 1.75 | (0.19) | 0.80 | (0.32) | 2.70***(L) | (0.21) | 1.40** | 0.31–2.50 |
13 weeks | 2.20 | (0.25) | 1.40 | (0.41) | 3.00***(L) | (0.29) | 1.10 | 0.48 to 2.68 |
CI, confidence interval; OR, odds ratio.
The significance levels for P values in this column are based on results of Wald tests.
The significance levels for P values in this column are based on results of Generalized Estimating Equations from baseline to respective end point (4 weeks or 13 weeks).
<0.1.
<0.05.
<0.01.
(S) and (L) refer to small and large effect sizes.